These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35413295)

  • 41. Cellular redox state protects acetaldehyde-induced alteration in cardiomyocyte function by modifying Ca2+ release from sarcoplasmic reticulum.
    Oba T; Maeno Y; Nagao M; Sakuma N; Murayama T
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H121-33. PubMed ID: 17982019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.
    Marx SO; Marks AR
    J Mol Cell Cardiol; 2013 May; 58():225-31. PubMed ID: 23507255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Ca(2+)-Dependent Protein-Protein Interactions within the Ca(2+) Release Units of Cardiac Sarcoplasmic Reticulum.
    Rani S; Park CS; Sreenivasaiah PK; Kim DH
    Mol Cells; 2016 Feb; 39(2):149-55. PubMed ID: 26674963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action.
    Ashna A; van Helden DF; Dos Remedios C; Molenaar P; Laver DR
    Mol Pharmacol; 2020 Apr; 97(4):250-258. PubMed ID: 32015008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.
    Uchinoumi H; Yang Y; Oda T; Li N; Alsina KM; Puglisi JL; Chen-Izu Y; Cornea RL; Wehrens XHT; Bers DM
    J Mol Cell Cardiol; 2016 Sep; 98():62-72. PubMed ID: 27318036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.
    Campbell HM; Quick AP; Abu-Taha I; Chiang DY; Kramm CF; Word TA; Brandenburg S; Hulsurkar M; Alsina KM; Liu HB; Martin B; Uhlenkamp D; Moore OM; Lahiri SK; Corradini E; Kamler M; Heck AJR; Lehnart SE; Dobrev D; Wehrens XHT
    Circulation; 2020 Sep; 142(12):1159-1172. PubMed ID: 32683896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.
    Zhang X; Tallini YN; Chen Z; Gan L; Wei B; Doran R; Miao L; Xin HB; Kotlikoff MI; Ji G
    Cardiovasc Res; 2009 Nov; 84(2):253-62. PubMed ID: 19578067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac Protein Kinase D1 ablation alters the myocytes β-adrenergic response.
    Mira Hernandez J; Ko CY; Mandel AR; Shen EY; Baidar S; Christensen AR; Hellgren K; Morotti S; Martin JL; Hegyi B; Bossuyt J; Bers DM
    J Mol Cell Cardiol; 2023 Jul; 180():33-43. PubMed ID: 37149124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triadin overexpression stimulates excitation-contraction coupling and increases predisposition to cellular arrhythmia in cardiac myocytes.
    Terentyev D; Cala SE; Houle TD; Viatchenko-Karpinski S; Gyorke I; Terentyeva R; Williams SC; Gyorke S
    Circ Res; 2005 Apr; 96(6):651-8. PubMed ID: 15731460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca
    Sun B; Wei J; Zhong X; Guo W; Yao J; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Chen SRW
    J Biol Chem; 2018 Aug; 293(35):13650-13661. PubMed ID: 29986885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RyR2 modulates a Ca2+-activated K+ current in mouse cardiac myocytes.
    Mu YH; Zhao WC; Duan P; Chen Y; Zhao WD; Wang Q; Tu HY; Zhang Q
    PLoS One; 2014; 9(4):e94905. PubMed ID: 24747296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake-leak balance of SR Ca
    Lopez R; Janicek R; Fernandez-Tenorio M; Courtehoux M; Matas L; Gerbaud P; Gomez AM; Egger M; Niggli E
    J Mol Cell Cardiol; 2022 Sep; 170():1-14. PubMed ID: 35644481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.
    van Oort RJ; McCauley MD; Dixit SS; Pereira L; Yang Y; Respress JL; Wang Q; De Almeida AC; Skapura DG; Anderson ME; Bers DM; Wehrens XH
    Circulation; 2010 Dec; 122(25):2669-79. PubMed ID: 21098440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca
    Yang J; Zhang R; Jiang X; Lv J; Li Y; Ye H; Liu W; Wang G; Zhang C; Zheng N; Dong M; Wang Y; Chen P; Santosh K; Jiang Y; Liu J
    J Biol Chem; 2018 Jan; 293(3):794-807. PubMed ID: 29150444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discordant Ca
    Sommese LM; Racioppi MF; Shen X; Orlowski A; Valverde CA; Louch WE; Vila Petroff M; Gonano LA
    Pflugers Arch; 2022 Jun; 474(6):625-636. PubMed ID: 35235009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. β2-adrenergic stimulation potentiates spontaneous calcium release by increasing signal mass and co-activation of ryanodine receptor clusters.
    Nolla-Colomer C; Casabella-Ramon S; Jimenez-Sabado V; Vallmitjana A; Tarifa C; Herraiz-Martínez A; Llach A; Tauron M; Montiel J; Cinca J; Chen SRW; Benitez R; Hove-Madsen L
    Acta Physiol (Oxf); 2022 Apr; 234(4):e13736. PubMed ID: 34709723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca
    Takenaka M; Kodama M; Murayama T; Ishigami-Yuasa M; Mori S; Ishida R; Suzuki J; Kanemaru K; Sugihara M; Iino M; Miura A; Nishio H; Morimoto S; Kagechika H; Sakurai T; Kurebayashi N
    Mol Pharmacol; 2023 Dec; 104(6):275-286. PubMed ID: 37678938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of RyR2 oxidation in the blunted frequency-dependent facilitation of Ca
    Bovo E; Mazurek SR; Zima AV
    Pflugers Arch; 2018 Jun; 470(6):959-968. PubMed ID: 29500669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.